.png){kind=icon}
R
Rohtesh S. Mehta
H指数:36
被引数:7,056
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation
比较造血干细胞移植后重型再生障碍性贫血长期存活者中供者类型对晚期效应和生活质量的影响
The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT
异基因造血干细胞移植中捐献者年龄分类的陷阱：任意截断点无法预测生存率
Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy
供者特异性HLA错配：单倍型与7/8位点错配无关供者造血干细胞移植联合PTCy
Absolute Risk Trade-offs of Donor Age, Sex, and Graft Source in PTCy-Based Transplantation
供者年龄、性别和移植物来源在PTCy方案移植中的绝对风险权衡
Blood Advances
IF7.1
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age
单倍型与匹配无关供者移植联合移植后环磷酰胺：基于平台的机器学习分析供者年龄
Leukemia
IF13.4
Challenging a clinical dogma with multimodal machine learning: a retrospective analysis of transplant mismatched donor selection
以多模态机器学习挑战临床教条：移植不匹配供者选择的一项回顾性分析
Leukemia
IF13.4
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis
建立供者年龄和类型权衡模型，以在采用移植后环磷酰胺预防措施的同种异基因造血细胞移植中进行个性化选择
Leukemia
IF13.4
Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
吉达西他滨在移植后高风险急性髓系白血病和骨髓增生异常综合征患者中改善了无复发生存期：单中心II期研究结果
Haematologica
IF7.9
The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide
移植后环磷酰胺支持下，无关供者造血细胞移植中孤立HLA-DQB1错配和供者年龄的影响
Comparative Outcomes of HCT with Post-Transplant Cyclophosphamide in Older Adults: The Impact of Donor Type
异基因造血干细胞移植中使用移植后环磷酰胺治疗老年患者：供者类型的影响
Blood Advances
IF7.1
Terlipressin for sinusoidal obstruction syndrome-associated acute kidney injury: a novel application
特利加压素用于肝小静脉阻塞综合征相关急性肾损伤：一种新用途
Terlipressin for sinusoidal obstruction syndrome-associated acute kidney injury: a novel application
曲普瑞林用于窦性阻塞综合征相关的急性肾损伤：一种新的应用
Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
单倍体相合与不合无关供者HCT在移植后环磷酰胺预防治疗下的结果
Blood Advances
IF7.1
Seizure Prophylaxis and its Impact on Busulfan Pharmacokinetics and Dosing in a Novel Timed Sequential Protocol: MD Anderson Experience
癫痫预防及其对新型定时序贯方案中马利兰药代动力学和剂量的影响：MD Anderson 经验
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
选择HLA错配无亲缘关系供体与单倍型相同供体：供体年龄的考量
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis
供者巨细胞病毒血清学状态在采用异基因供者造血细胞移植并接受术后环磷酰胺预防的巨细胞病毒血清学阴性受者中的作用
